We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Like many cancer patients, Michael Wolff wanted answers. But, like many cancer patients in 2015, he wasn't getting them.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its ...

The newly unveiled database showcases the genome sequences of healthy individuals from 99 ethnic populations of the country, ...

Human Longevity, Inc. (HLI) and SleepScore Labs today announced a strategic partnership aimed at revolutionizing sleep health ...

Nagpur: Samples of the two city children, who had tested positive for human metapneumovirus (HMPV) at a private hospital lab ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and ...

A new study outlines the ways by which city life may be shaping the evolution of urban coyotes, the highly adaptable carnivores spotted in alleyways from Berkeley, Calif., to the Bronx, in New York.

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...